Osaic Holdings
COEPW

Osaic Holdings’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Osaic Holdings’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,469
Closed -$189 – 7764
2025
Q1 		$189 Buy
+17,469
New +$458 ﹤0.01% 7169

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Osaic Holdings's COEPW Position: Q2 2025 in Review

Osaic Holdings sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2025, closing a stake of 17,469 shares — an estimated $189 sold.

Osaic Holdings first reported a position in COEPW in Q1 2025 and held it in 1 quarter. The position peaked at $189 in Q1 2025. 13 funds tracked by Wall St. Rank hold COEPW as of Q2 2025.

  • Osaic Holdings reported no remaining Coeptis Therapeutics Warrants position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 17,469 Coeptis Therapeutics Warrants shares in Q2 2025, an estimated $189.
  • Osaic Holdings first reported a position in Coeptis Therapeutics Warrants in Q1 2025 and held it in 1 quarter.
  • Osaic Holdings's Coeptis Therapeutics Warrants position peaked at $189 in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.